ARTICLE
TITLE

An analysis of pro-vaccine and anti-vaccine information on social networks and the internet: Visual and emotional patterns

SUMMARY

The communication of information about vaccines and anti-vaccines is analyzed through the monitoring of issuers, news sites, groups, and messages in social networks. We also investigate the effects of information on people’s attention, emotion, and engagement, which were analyzed using eye tracking, galvanic skin response (GSR) and facial expression methods. Results: the flow of communication was not constant, both in the press and on web sites (376 news in 2015, 74 in 2016, 69 in 2017 and, 268 in 2018); posts were informative and neutral; and 80% came from non-professional sources (only 17% were written by a journalist and 3% by a health specialist). On social networks, anti-vaccine Facebook messages and groups were identified, and a mapping of influencers is presented. Analysis of the temporal evolution (years 2015 to 2018) of communicative flows showed that anti-vaccine posts decreased. Gender differences appeared in the visual exploration of information sources and in the provoked emotion responses (GSR and facial expression). In pro-vaccine pages women looked at the headline first, while men looked at the photograph. Emotional responses and engagement did not show differences between anti-vaccine and pro-vaccine web sites. No differences were found in the emotion provoked (GSR) between both website types: anti-vaccination persuasion occurred via cognitive, not emotional, methods by using heuristics (e.g., conspiracy theories). Emotional responses and engagement did not show differences between pro-vaccine and anti-vaccine web sites.

 Articles related

A.N. Gamal Maha,M. S. El-Nagar Eman,M. El-Hady,M. Saad,Y. A. Soliman    

Infectious Laryngotracheitis (ILT) is an economically important disease of poultry, causing a high mortality rate and /or reduced egg production. Tracheas from sever morbid and recently died unvaccinated household chicken were subjected to PCR assay to d... see more


André T. J. Alves, Flávio F. Nobre    

Despite increased funding for research on the human immunodeficiency virus (HIV) and the acquired immunodeficiency syndrome (AIDS), neither vaccine nor cure is yet in sight. Surveillance and prevention are essential for disease intervention, and it is re... see more


Azadeh Bahadoran ,Hassan Moeini ,Mohd Hair Bejo ,Mohd Zobir Hussein ,Abdul Rahman Omar    

PURPOSE: In order to enhance cellular uptake and to facilitate transdermal delivery of DNA vaccine, polyamidoamine (PAMAM) dendrimers conjugated with HIV transactivator of transcription (TAT) was developed. METHODS: First, the plasmid DNA (pIRES-H5/GFP) ... see more


Nyimas Heny Purwati, Yeni Rustina, Bambang Supriyatno    

Background Childhood community-acquired pneumonia (CAP) is one of the leading causes of morbidity and mortality in children under five years of age.Objective To explore the unmet needs of family caregivers of children with community-acquired pneumonia.Me... see more


Las buenas prácticas clínicas. Su aplicación en el dato primario para los eventos adversos / Good clinical practices and its use in primary data in adverse eventsLas buenas prácticas clínicas. Su aplicación en el dato primario para los eventos adversos / Good clinical practices and its use in primary data in adverse eventsLas Buenas Prácticas Clínicas son estándares nacionales e internacionales con que se realizan los Ensayos Clínicos. El ejercicio de dichas prácticas ofrece credibilidad y confiabilidad a los datos aportados por la etapa de desarrollo clínico del producto en investigación; respecto a los derechos e integridad del paciente y guían al trabajador de la salud. El Evento Adverso tiene que ser recogido en el documento primario con todas sus características y transcrito al Cuaderno de Recogida de Datos de cada sujeto en investigación. Durante el l Ensayo Clínico, el sujeto en estudio puede presentar síntomas o signos desfavorables con o sin relación causal con el producto. Se revisaron nueve Historias Clínicas y sus respectivos Cuadernos de Recogida de Datos de los pacientes portadores de cáncer de próstata hormona-refractario, incluidos en el Ensayo Clínico Fase II "Evaluación clínica del uso del esquema vacuna-quimioterapia-vacuna con la vacuna de Factor de Crecimiento Epidérmico en el tratamiento de estos pacientes, tratados en el sitio de investigación Hospital 3er Congreso de Pinar del Río. Se usaron métodos estadísticos de análisis. Los eventos adversos más frecuentes resultaron las alteraciones en los exámenes de laboratorio clínicos en un 100% de los pacientes, seguidos de los digestivos 88.9% del total de pacientes. Hubo un 94% de correspondencia en la trascripción del dato del evento adverso al cuaderno de recogida de datos; un 94.1% de los eventos fueron clasificados adecuadamente y un 92.2% transcritos correctamente en el CRD. El 100% de los eventos adversos tuvo un criterio de percepción. Recomendamos monitoreos internos periódicos a cada EC del sitio. Palabras clave: Prácticas Clínicas, Ensayos Clínicos como Asunto, Investigación Biomédica., Proyectos de Investigación. ABSTRACT The good clinical practices are national or international standards for the clinical assays; these practices give credibility and confidence to data given by the stage of the clinical development of the product to be investigated. The adverse event has to be compiled in the primary document with all the characteristics and transcribed to the notebook of data in every subject in the investigation. During the I Clinical Assay, the subject may have symptoms or unfavourable signs with causal relationship with the product or not. Nine clinical records as well as its respective notebooks for data in carriers of the hormone-refractory prosthatic cancer included in the Fase II Clinical assay "Clinical evaluation of the use of the vaccine-chemotherapy -vaccine using the epidermic growing factor in the treatment of these patients were treated in "III Congreso"Pinar del Rio hospital. Statistical analysis methods were used. The most frequent adverse events were: changes in the clinical laboratory tests (100 %), followed by 94% of correspondence in the transcription data of the adverse event into the notebook of data; 94..1% of the events were properly classified and a 92.2% were transcribed properly in the CDR (Revolution Defence Committee).100 per cent of the adverse events had a perception criterion. It is recommended periodical internal monitoring in every CA of the site. Key words: Clinical Practices, Clinical Assays as an Event, Biomedical Investigation, Investigation Project

Rosa M. Amador González,Teresa Llera Clausell,Karina Miranda Hernández,Yoryana Ramírez Sánchez,Bárbara Iglesias Castillo